Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance in Posttraumatic Stress

Clinical trial NCT03642028 · RECRUITING

Trial details

NCT number: NCT03642028
Sponsor: VA Office of Research and Development
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Sleep Initiation and Maintenance Disorders Stress Disorders, Posttraumatic

Start date: 2019-08-30
Primary completion: 2025-12-31
Enrollment: 190

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.